Synergistic effect of posaconazole and caspofungin against clinical zygomycetes.
about
Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia speciesThe strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus.Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.Drug combinations against Mucor irregularis in vitro.In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.Outbreak of intestinal infection due to Rhizopus microsporus.Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropeniaUse of posaconazole in the treatment of invasive fungal infections.Posaconazole: when and how? The clinician's view.Combination antifungal therapy for invasive fungal infections in children and adults.Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.Our 2014 approach to mucormycosis.Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs.Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview.Internal transcribed spacer region sequence heterogeneity in Rhizopus microsporus: implications for molecular diagnosis in clinical microbiology laboratories.Mucormycosis in Children: Review and Recommendations for Management.In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
P2860
Q28389719-4995828F-27A8-46BE-B686-AB9D195D4C79Q35076940-4854FEB9-D0E3-4FF2-840D-2C118403B361Q36744800-CBF7212C-8961-4B0A-B119-5E03DA5F96F0Q36969929-8970BA24-DD0E-4EE4-864A-016A85E6E036Q37274705-69796129-8D53-4A0E-8230-791A115FF9EDQ37333687-394C1CAC-C2CD-437E-8AF0-A33AB1EBCA98Q37404840-F12758FF-44C1-4FFD-81C7-947FB6091811Q37451673-B6795E98-4022-4FE7-BA32-38A80182BDBAQ37810083-1B27432F-E8E6-488D-A4D6-CADFF235EEE7Q37901534-98C8E617-54C2-4595-932A-6B8D9A54D29BQ38102782-40AC414A-0114-423B-BDAF-DA832A6FC168Q38193337-301EFF87-2F83-45B3-BE64-50D36693829CQ38211830-93093051-D7F6-4900-A6F9-9202230BDB67Q38245046-2C2C5C67-C0A4-45A0-BBAF-6308C5660A06Q42413286-97C9B3CB-2D58-4D24-B410-B2F11BC7F56DQ42929534-8104E03A-8F79-4B6F-A66A-B56A10FC13CDQ47222680-3D21DEBE-5A3C-48ED-A30A-3DD4CF04EB4BQ50755451-CCAA714B-83A1-4CB7-A072-6DE3FAA9A699
P2860
Synergistic effect of posaconazole and caspofungin against clinical zygomycetes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Synergistic effect of posaconazole and caspofungin against clinical zygomycetes.
@en
Synergistic effect of posaconazole and caspofungin against clinical zygomycetes.
@nl
type
label
Synergistic effect of posaconazole and caspofungin against clinical zygomycetes.
@en
Synergistic effect of posaconazole and caspofungin against clinical zygomycetes.
@nl
prefLabel
Synergistic effect of posaconazole and caspofungin against clinical zygomycetes.
@en
Synergistic effect of posaconazole and caspofungin against clinical zygomycetes.
@nl
P2093
P2860
P356
P1476
Synergistic effect of posaconazole and caspofungin against clinical zygomycetes.
@en
P2093
Jesús Guinea
Marta Torres-Narbona
María Guembe
Teresa Peláez
P2860
P304
P356
10.1128/AAC.00595-07
P407
P50
P577
2007-06-18T00:00:00Z